PACS Group, Inc.

NYSE:PACS

Financial - Conglomerates

Financial Services
$46.30 +1.16%

+$0.41 today

Market cap
$7.35B
Beta
0.00
P/E (TTM)
23.0
EPS (TTM)
$1.55
52W Low $7.50High $43.08

Volume 0.78M

Average 0.84M

PACS Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

PACS Group, Inc.NYSE: PACS

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue grows, but more slowly than its trailing trend

Q2 FY2026 cost of revenue of $1.09B rose 6.7% year over year, behind the +11.5% change in trailing-twelve-month cost of revenue. Sequentially, it fell 8.3% from the prior quarter. Over 3 fiscal years it compounded at +26.9% a year.

Context

  • Cost of revenue amounted to 78.1% of revenue in FY2025, down 2.5 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +6.7% toward the trailing-twelve-month pace of +11.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.09B-8.3% QoQ
Last fiscal yearDec 2025
$4.13B+25.3% YoY
LTMJun 2026
$4.46B+11.5% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.7%——
1 year+25.3%——
3-year CAGR+26.9%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
4.13B USD
Year-over-year change
+25.3%
4-year CAGR
+43.3%

Cost of Revenue vs competitors

How PACS compares with its peers on the latest reported figures

  • PACS's LTM Jun 2026 cost of revenue of $4.46B is the 4th highest of the 11 companies compared; the peer median is $1.8B.
  • Its year-over-year change of +11.5% is the 8th highest of 11, against a peer median of +19.9%.
  • Cost of revenue amounts to 80.3% of revenue for PACS, versus a peer median of 69.8%.
PACS Competitors Peer median
Cost of Revenue for PACS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$55.89B +30.1%+6.1%71.6%
CYHCommunity Health Systems, Inc.LTM Mar 2026$9.96B +35.0%+16.0%46.3%
ENSGThe Ensign Group, Inc.LTM Jun 2026$4.71B +21.3%+19.3%85.9%
PACSPACS Group, Inc.LTM Jun 2026$4.46B +11.5%+26.9%80.3%
EHCEncompass Health CorporationLTM Jun 2026$3.48B +6.6%+9.1%56.1%
BKDBrookdale Senior Living Inc.LTM Sep 2026$2.52B +11.2%+3.6%85.5%
NHCNational HealthCare CorporationLTM Sep 2026$1.08B +16.9%+10.3%68.0%
LFSTLifeStance Health Group, Inc.LTM Jun 2026$1.05B +18.5%+15.7%66.4%
PNTGThe Pennant Group, Inc.LTM Mar 2026$871.95M +35.1%+25.8%85.2%
INNVInnovAge Holding Corp.LTM Mar 2026$749.65M +9.8%-21.8%79.3%
NUTXNutex Health, Inc.LTM Mar 2026$462.28M +44.5%+28.3%52.5%
Peer median (excluding PACS) $1.8B+19.9%+13.0%69.8%

Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.17B2.42B3.11B4.09B5.29B
Cost of Revenue979.22M2.02B2.66B3.3B4.13B
Gross Profit187.35M400.68M447.07M792.64M1.16B
Gross Margin16.1%16.5%14.4%19.4%21.9%
Research & Development00000
Selling, General & Admin96.83M149.01M213.66M343.81M415.07M
Operating Expenses103.99M171.32M239.3M669.57M849.64M
Depreciation & Amortization7.15M22.31M25.63M40.81M55.66M
EBITDA93.86M254.89M232.87M186.7M365.57M
EBITDA Margin8.0%10.5%7.5%4.6%6.9%
Operating Income83.36M229.36M207.77M123.07M309.6M
Operating Margin7.1%9.5%6.7%3.0%5.9%
Interest Income00000
Interest Expense5.28M25.54M49.92M44.34M28.36M
Other Income / Expenses(1.93M)(22.32M)(50.46M)(21.52M)(25.15M)
Income Before Tax81.43M207.05M157.32M101.55M284.45M
Pre-Tax Margin7.0%8.5%5.1%2.5%5.4%
Income Tax Expense33.48M56.55M44.44M46.21M92.99M
Net Income47.95M150.5M112.87M55.76M191.54M
Net Margin4.1%6.2%3.6%1.4%3.6%
EPS (Basic)0.321.000.750.381.23
EPS (Diluted)0.321.000.750.381.22
Weighted Avg Shares150.15M150.15M150.15M146.66M156.18M
Weighted Avg Shares (Diluted)150.15M150.15M150.15M148.57M156.7M

PACS Group, Inc.

NYSE:PACS

Intrinsic Alpha fair value

Locked

Current Price

$46.30

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.